Quest Diagnostics Incorporated
DGX
$173.76
-$2.11-1.20%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.09% | 14.55% | 8.41% | 2.52% | 1.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.09% | 14.55% | 8.41% | 2.52% | 1.50% |
| Cost of Revenue | 12.71% | 13.37% | 8.64% | 2.78% | 2.06% |
| Gross Profit | 10.84% | 17.03% | 7.94% | 2.02% | 0.38% |
| SG&A Expenses | 6.19% | 12.78% | 15.20% | 0.74% | 1.40% |
| Depreciation & Amortization | 34.48% | 37.04% | 18.52% | 3.57% | 11.54% |
| Other Operating Expenses | 0.00% | 300.00% | -200.00% | -- | -200.00% |
| Total Operating Expenses | 11.63% | 13.73% | 9.94% | 2.43% | 1.94% |
| Operating Income | 15.00% | 19.87% | 0.00% | 3.05% | -1.23% |
| Income Before Tax | 7.30% | 24.08% | -0.98% | -3.09% | -2.84% |
| Income Tax Expenses | -10.61% | 70.00% | -4.41% | -1.33% | 1.54% |
| Earnings from Continuing Operations | 12.98% | 15.12% | 0.00% | -3.61% | -4.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.14% | -7.69% | 8.33% | 21.43% | 6.67% |
| Net Income | 13.40% | 15.63% | 0.44% | -2.55% | -3.96% |
| EBIT | 15.00% | 19.87% | 0.00% | 3.05% | -1.23% |
| EBITDA | 16.51% | 20.91% | 3.02% | 3.38% | 1.16% |
| EPS Basic | 13.48% | 15.62% | 0.89% | -1.68% | -3.11% |
| Normalized Basic EPS | 7.51% | 13.24% | -2.13% | 0.51% | -1.07% |
| EPS Diluted | 12.79% | 20.21% | 1.53% | -0.98% | -3.37% |
| Normalized Diluted EPS | 6.56% | 12.22% | -1.27% | 1.40% | -1.08% |
| Average Basic Shares Outstanding | 0.00% | -0.89% | 0.00% | -0.89% | -0.89% |
| Average Diluted Shares Outstanding | 0.89% | 0.00% | -0.88% | -1.75% | -0.88% |
| Dividend Per Share | 6.67% | 5.63% | 5.63% | 5.63% | 5.63% |
| Payout Ratio | -0.06% | -0.09% | 0.05% | 0.08% | 0.11% |